Cambridge Innovation Capital
Europe HQ
Seed Series-A
Last updated 21 Sep 2026
Website ↗
01 · Thesis & focus
Cambridge-based fund managing over £500M, one of the most active Series A deeptech and life sciences investors in the Cambridge ecosystem (Pragmatic, Riverlane, Gyroscope); launched a £100M Opportunity Fund in 2025 backed by Aviva and British Patient Capital. A major established UK deeptech Series A lead.
Cheque range
Undisclosed
Stages
Seed, Series A
Avg deals / year
–
Leads rounds
Yes
HQ
Cambridge
Fund type
Venture fund
02 · Recent publicly announced deals
No recent deals recorded.
03 · Similar firms
Refresh this card
A research agent will check public sources for recent deals, fund news and firm details, then update the card. Know of a specific announcement? Paste links below (press articles or the fund's own site) and it will check those too.